IGURA 25 mg Tablet contains Empagliflozin 25 mg. It is an oral antidiabetic medicine belonging to the SGLT2 inhibitor group, used to improve blood glucose control in patients with type 2 diabetes mellitus.
Uses:
Treatment of type 2 diabetes mellitus
Helps lower blood glucose levels along with diet and exercise
Reduces glucose reabsorption in the kidneys and increases glucose removal through urine
Helps reduce the risk of cardiovascular complications in eligible patients
Used for heart failure and kidney protection in certain patients as prescribed
Dose:
Adults: Usually 25 mg once daily or as directed by a physician
Can be taken with or without food
Take the medicine at the same time each day
Dose depends on blood glucose level, kidney function, and response to treatment
Follow the prescribed dose and duration as advised by a healthcare professional